A Study to Evaluate the Effect of Food, Formulation, and a Proton Pump Inhibitor (PPI) on MK-1084 in Healthy Adult Participants (MK-1084-003)
PHASE1CompletedINTERVENTIONAL
Enrollment
56
Participants
Timeline
Start Date
September 20, 2023
Primary Completion Date
November 25, 2023
Study Completion Date
November 25, 2023
Conditions
Healthy
Interventions
DRUG
MK-1084
Oral Tablet
DRUG
PPI
Oral Capsule
Trial Locations (1)
68502
Celerion (Site 0001), Lincoln
All Listed Sponsors
lead
Merck Sharp & Dohme LLC
INDUSTRY
NCT06619314 - A Study to Evaluate the Effect of Food, Formulation, and a Proton Pump Inhibitor (PPI) on MK-1084 in Healthy Adult Participants (MK-1084-003) | Biotech Hunter | Biotech Hunter